EZH2 can be used as a therapeutic agent for inhibiting endothelial dysfunction

Biochem Pharmacol. 2023 Jul:213:115594. doi: 10.1016/j.bcp.2023.115594. Epub 2023 May 18.

Abstract

Enhancer of zeste homolog 2 (EZH2) is a catalytic subunit of polycomb repressor complex 2 and plays important roles in endothelial cell homeostasis. EZH2 functionally methylates lysine 27 of histone H3 and represses gene expression through chromatin compaction. EZH2 mediates the effects of environmental stimuli by regulating endothelial functions, such as angiogenesis, endothelial barrier integrity, inflammatory signaling, and endothelial mesenchymal transition. Numerous studies have been conducted to determine the significance of EZH2 in endothelial function. The aim of this review is to provide a concise summary of the roles EZH2 plays in endothelial function and elucidate its therapeutic potential in cardiovascular diseases.

Keywords: Angiogenesis; EZH2; Endothelial barrier; Endothelial cells; Endothelial mesenchymal transition; Inflammatory signaling.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Chromatin
  • Endothelial Cells / metabolism
  • Enhancer of Zeste Homolog 2 Protein* / metabolism
  • Histones / metabolism
  • Humans
  • Polycomb Repressive Complex 2* / genetics
  • Polycomb Repressive Complex 2* / metabolism

Substances

  • Chromatin
  • Enhancer of Zeste Homolog 2 Protein
  • Histones
  • Polycomb Repressive Complex 2
  • EZH2 protein, human